Why Monkeypox Is Making Some College Kids Nervous Right Now

Mount Sinai Awarded Five-Year, $20.7 Million Vaccine Development Agreement to Advance Next-Generation Technologies Against Respiratory Threats

Mount Sinai Researcher Appointed to National Academies Committee Examining Neurocognitive Effects of SARS-CoV-2 Across the Lifespan

Two Mount Sinai Researchers Named Inaugural Cumming Global Fellows for Pandemic Therapeutics Research

Wisp Collaborates with Mount Sinai to Expand Access to PrEP and HIV Prevention Across New York State

Mount Sinai Scientists Identify Three Potent Human Antibodies Against Mpox, Paving the Way for New Protective Therapies

Mount Sinai Researchers Develop Method to Identify Dormant Cells That Carry HIV

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

Mount Sinai Receives $6.2 Million Grant from the Steven & Alexandra Cohen Foundation for the Clinical Care of Long Lyme Disease

Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.

Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV

Mount Sinai Receives NIH Grant to Develop Vaccines That Can Protect Against Many Different Types of Coronaviruses